{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:22:07Z","timestamp":1791379327649,"version":"4.3.2"},"reference-count":37,"publisher":"MedWorks Media","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacol Bull"],"abstract":"<jats:p>Patients with severe mental illness (SMI) who do not adhere to treatment have a lower quality of life, with more hospitalizations, interpersonal relationship conflict, homelessness, substance use problems, and incarceration compared to patients who adhere to treatment. Nonadherence to psychiatric medications has been studied for over a decade in patients diagnosed with bipolar, schizoaffective, and schizophrenia disorders with long-acting injectable antipsychotics (LAI) becoming a mainstay of adherence-focused treatment. Previous studies have shown that LAI treatment can be further optimized with the inclusion of the behavioral intervention, Customized Adherence Enhancement (CAE). It was unclear if outcomes improved similarly across the studies that varied by demographics, diagnoses, and CAE + LAI protocols. We aimed to evaluate CAE + LAI adherence outcomes in SMI by pooling three studies to better understand response to treatment in the setting of varied circumstances. Our findings show that adherence improved similarly across studies despite these differences. Furthermore, it was demonstrated that CAE + LAI improved adherence to a similar degree when primary mood and psychotic disorder cohorts were compared. As the use of LAI expands, our findings show the versatility and effectiveness of including CAE to further optimize adherence and improve other outcomes.<\/jats:p>","DOI":"10.64719\/pb.4443","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:39:16Z","timestamp":1761046756000},"page":"41-57","source":"Crossref","is-referenced-by-count":0,"title":["Combining Medication Adherence Support Plus Long-Acting Injectable Antipsychotic Medication: A Post-Hoc Analysis of 3 Pilot Studies"],"prefix":"10.64719","volume":"52","author":[{"given":"Thomas","family":"Canales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Rodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danette","family":"Conklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaylee","family":"Sarna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Sajatovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer B","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54175","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Hassan M, Lage MJ. Risk of rehospitalization among bipolar disorder patients who are nonadherent to antipsychotic therapy after hospital discharge. Am J Health Syst Pharm. 2009;66(4):358\u2013365. doi: 10.2146\/ajhp080374. doi:","DOI":"10.2146\/ajhp080374"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Hong J, Reed C, Novick D, Haro JM, Aguado J. Clinical and economic consequences of medication non-adherence in the treatment of patients with a manic\/mixed episode of bipolar disorder: results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) study. Psychiatry Res. 2011;190(1):110\u2013114. doi: 10.1016\/j.psychres.2011.04.016. doi:","DOI":"10.1016\/j.psychres.2011.04.016"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Keck PE, McElroy SL, Strakowski SM et al. 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am J Psychiatry. 1998;155(5):646\u2013652. doi: 10.1176\/ajp.155.5.646. doi:","DOI":"10.1176\/ajp.155.5.646"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Li C, Chen C, Qiu B, Yang G. A 2-year follow-up study of discharged psychiatric patients with bipolar disorder. Psychiatry Res. 2014;218(1\u20132):75\u201378. doi: 10.1016\/j.psychres.2014.04.029. doi:","DOI":"10.1016\/j.psychres.2014.04.029"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Scott J, Pope M. Nonadherence with mood stabilizers: prevalence and predictors. J Clin Psychiatry. 2002;63(5):384\u2013390.","DOI":"10.4088\/JCP.v63n0502"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Svarstad BL, Shireman TI, Sweeney JK. Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatr Serv. 2001;52(6):805\u2013811. doi: 10.1176\/appi.ps.52.6.805. doi:","DOI":"10.1176\/appi.ps.52.6.805"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Copeland LA, Miller AL, Welsh DE, McCarthy JF, Zeber JE, Kilbourne AM. Clinical and demographic factors associated with homelessness and incarceration among VA patients with bipolar disorder. Am J Public Health. 2009;99(5):871\u2013877. doi: 10.2105\/AJPH.2008.149989. doi:","DOI":"10.2105\/AJPH.2008.149989"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Robertson AG, Swanson JW, Van Dorn RA, Swartz MS. Treatment participation and medication adherence: effects on criminal justice costs of persons with mental illness. Psychiatr Serv. 2014;65(10):1189\u20131191. doi: 10.1176\/appi.ps.201400247. doi:","DOI":"10.1176\/appi.ps.201400247"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Levin JB, Krivenko A, Howland M, Schlachet R, Sajatovic M. Medication Adherence in Patients with Bipolar Disorder: A Comprehensive Review. CNS Drugs. 2016;30(9):819\u2013835. doi: 10.1007\/s40263-016-0368-x. doi:","DOI":"10.1007\/s40263-016-0368-x"},{"key":"ref10","unstructured":"Kondo K, Low A, Jindai K et al. Interventions to Improve Pharmacological Adherence Among Adults with Psychotic Spectrum Disorders, Bipolar Disorder, and Posttraumatic Stress Disorder. 2015"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Barkhof E, Meijer CJ, de Sonneville LM, Linszen DH, de Haan L. Interventions to improve adherence to antipsychotic medication in patients with schizophrenia\u2014a review of the past decade. Eur Psychiatry. 2012;27(1):9\u201318. doi: 10.1016\/j.eurpsy.2011.02.005. doi:","DOI":"10.1016\/j.eurpsy.2011.02.005"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Lincoln TM, Wilhelm K, Nestoriuc Y. Effectiveness of psychoeducation for relapse, symptoms, knowledge, adherence and functioning in psychotic disorders: a meta-analysis. Schizophr Res. 2007;96(1\u20133):232\u2013245. doi: 10.1016\/j.schres.2007.07.022. doi:","DOI":"10.1016\/j.schres.2007.07.022"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"McKenzie K, Chang YP. The effect of nurse-led motivational interviewing on medication adherence in patients with bipolar disorder. Perspect Psychiatr Care. 2015;51(1):36\u201344. doi: 10.1111\/ppc.12060. doi:","DOI":"10.1111\/ppc.12060"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Depp CA, Lebowitz BD, Patterson TL, Lacro JP, Jeste DV. Medication adherence skills training for middle-aged and elderly adults with bipolar disorder: development and pilot study. Bipolar Disord. 2007;9(6):636\u2013645. doi: 10.1111\/j.1399-5618.2007.00397.x. doi:","DOI":"10.1111\/j.1399-5618.2007.00397.x"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Wenze SJ, Gaudiano BA, Weinstock LM, Tezanos KM, Miller IW. Adjunctive psychosocial intervention following Hospital discharge for Patients with bipolar disorder and comorbid substance use: A pilot randomized controlled trial. Psychiatry Res. 2015;228(3):516\u2013525. doi: 10.1016\/j.psychres.2015.06.005. doi:","DOI":"10.1016\/j.psychres.2015.06.005"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Moore DJ, Poquette A, Casaletto KB et al. Individualized texting for adherence building (iTAB): improving antiretroviral dose timing among HIV-infected persons with co-occurring bipolar disorder. AIDS Behav. 2015;19(3):459\u2013471. doi: 10.1007\/s10461-014-0971-0. doi:","DOI":"10.1007\/s10461-014-0971-0"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Priebe S, Yeeles K, Bremner S et al. Effectiveness of financial incentives to improve adherence to maintenance treatment with antipsychotics: cluster randomised controlled trial. BMJ. 2013;347:f5847. doi: 10.1136\/bmj.f5847. doi:","DOI":"10.1136\/bmj.f5847"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Sajatovic M, Levin J, Tatsuoka C et al. Customized adherence enhancement for individuals with bipolar disorder receiving antipsychotic therapy. Psychiatr Serv. 2012;63(2):176\u2013178. doi: 10.1176\/appi.ps.201100133. doi:","DOI":"10.1176\/appi.ps.201100133"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Sajatovic M, Levin J, Tatsuoka C et al. Six-month outcomes of customized adherence enhancement (CAE) therapy in bipolar disorder. Bipolar Disord. 2012;14(3):291\u2013300. doi: 10.1111\/j.1399-5618.2012.01010.x. doi:","DOI":"10.1111\/j.1399-5618.2012.01010.x"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Sajatovic M, Levin JB, Ramirez LF et al. Long-Acting Injectable Antipsychotic Medication Plus Customized Adherence Enhancement in Poor Adherence Patients With Bipolar Disorder. Prim Care Companion CNS Disord. 2021;23(5) doi: 10.4088\/PCC.20m02888. doi:","DOI":"10.4088\/PCC.20m02888"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Sajatovic M, Levin J, Ramirez LF et al. Prospective trial of customized adherence enhancement plus long-acting injectable antipsychotic medication in homeless or recently homeless individuals with schizophrenia or schizoaffective disorder. J Clin Psychiatry. 2013;74(12):1249\u20131255. doi: 10.4088\/JCP.12m08331. doi:","DOI":"10.4088\/JCP.12m08331"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Sajatovic M, Ramirez LF, Fuentes-Casiano E et al. A 6-Month Prospective Trial of a Personalized Behavioral Intervention + Long-Acting Injectable Antipsychotic in Individuals With Schizophrenia at Risk of Treatment Nonadherence and Homelessness. J Clin Psychopharmacol. 2017;37(6):702\u2013707. doi: 10.1097\/JCP.0000000000000778. doi:","DOI":"10.1097\/JCP.0000000000000778"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Scott J, Pope M. Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization. Am J Psychiatry. 2002;159(11):1927\u20131929. doi: 10.1176\/appi.ajp.159.11.1927. doi:","DOI":"10.1176\/appi.ajp.159.11.1927"},{"key":"ref24","unstructured":"Homeless Emergency Assistance and Rapid Transition to Housing: Defining \u201cHomeless\u201d. 2011:26. In: Department DoHaUD, editor. 76 FR 75994. Federal Register: Office of the Federal Register, National Archives and Records Administration."},{"key":"ref25","unstructured":"Institute SAS, Books24x I. SAS Stat Studio 3.11: user\u2019s guide. 2009 SAS documentation. SAS Institute Inc."},{"key":"ref26","unstructured":"Cheng-Fang Y, Cheng-Sheng C, Chih-Hung K et al. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: Prospective study. 2005:365\u2013510. Psychiatry and Clinical Neurosciences: Japanese Society of Psychiatry and Neurology."},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Nos\u00e9 M, Barbui C, Tansella M. How often do patients with psychosis fail to adhere to treatment programmes. Psychol Med. 2003;33(7):1149\u20131160. doi: 10.1017\/s0033291703008328. A systematic review. doi:","DOI":"10.1017\/s0033291703008328"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Sajatovic M, Davies MA, Ganocy SJ et al. A comparison of the life goals program and treatment as usual for individuals with bipolar disorder. Psychiatr Serv. 2009;60(9):1182\u20131189. doi: 10.1176\/ps.2009.60.9.1182. doi:","DOI":"10.1176\/ps.2009.60.9.1182"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Levin JB, Aebi ME, Howland M et al. The Relationship Between Medication Attitudes and Medication Adherence Behavior in Adults With Bipolar Disorder. J Nerv Ment Dis. 2020;208(2):87\u201393. doi: 10.1097\/NMD.0000000000001083. doi:","DOI":"10.1097\/NMD.0000000000001083"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Argyelan M, Ikuta T, DeRosse P et al. Resting-state fMRI connectivity impairment in schizophrenia and bipolar disorder. Schizophr Bull. 2014;40(1):100\u2013110. doi: 10.1093\/schbul\/sbt092. doi:","DOI":"10.1093\/schbul\/sbt092"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Bora E, Pantelis C. Meta-analysis of Cognitive Impairment in First-Episode Bipolar Disorder: Comparison With First-Episode Schizophrenia and Healthy Controls. Schizophr Bull. 2015;41(5):1095\u2013104. doi: 10.1093\/schbul\/sbu198. doi:","DOI":"10.1093\/schbul\/sbu198"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Krabbendam L, Arts B, van Os J, Aleman A. Cognitive functioning in patients with schizophrenia and bipolar disorder: a quantitative review. Schizophr Res. 2005;80(2\u20133):137\u2013149. doi: 10.1016\/j.schres.2005.08.004. doi:","DOI":"10.1016\/j.schres.2005.08.004"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Stefanopoulou E, Manoharan A, Landau S, Geddes JR, Goodwin G, Frangou S. Cognitive functioning in patients with affective disorders and schizophrenia: a meta-analysis. Int Rev Psychiatry. 2009;21(4):336\u2013356. doi: 10.1080\/09540260902962149. doi:","DOI":"10.1080\/09540260902962149"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Li W, Zhou FC, Zhang L et al. Comparison of cognitive dysfunction between schizophrenia and bipolar disorder patients: A meta-analysis of comparative studies. J Affect Disord. 2020;274:652\u2013661. doi: 10.1016\/j.jad.2020.04.051. doi:","DOI":"10.1016\/j.jad.2020.04.051"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Shahab S, Mulsant BH, Levesque ML et al. Brain structure, cognition, and brain age in schizophrenia, bipolar disorder, and healthy controls. Neuropsychopharmacology. 2019;44(5):898\u2013906. doi: 10.1038\/s41386-018-0298-z. doi:","DOI":"10.1038\/s41386-018-0298-z"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Velthorst E, Fett AJ, Reichenberg A et al. The 20-Year Longitudinal Trajectories of Social Functioning in Individuals With Psychotic Disorders. Am J Psychiatry. 2017;174(11):1075\u20131085. doi: 10.1176\/appi.ajp.2016.15111419. doi:","DOI":"10.1176\/appi.ajp.2016.15111419"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Garfield S, Clifford S, Eliasson L, Barber N, Willson A. Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review. BMC Med Res Methodol. 2011;11:149. doi: 10.1186\/1471-2288-11-149. doi:","DOI":"10.1186\/1471-2288-11-149"}],"container-title":["Psychopharmacology Bulletin"],"original-title":[],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:31:11Z","timestamp":1791315071000},"score":1,"resource":{"primary":{"URL":"https:\/\/medworksmedia.com\/pb-article\/combining-medication-adherence-support-plus-long-acting-injectable-antipsychotic-medication-a-post-hoc-analysis-of-3-pilot-studies\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,8,12]]}},"URL":"https:\/\/doi.org\/10.64719\/pb.4443","relation":{},"ISSN":["2472-2448"],"issn-type":[{"value":"2472-2448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]}}}